Ryan Specialty (NYSE:RYAN) Given “Equal Weight” Rating at Wells Fargo & Company

Wells Fargo & Company reaffirmed their equal weight rating on shares of Ryan Specialty (NYSE:RYAN) in a research note released on Friday, MarketBeat Ratings reports. The firm currently has a $31.00 price objective on the stock, down from their previous price objective of $42.00.

Several other analysts have also recently weighed in on the company. JPMorgan Chase & Co. dropped their price objective on Ryan Specialty from $49.00 to $43.00 and set an “underweight” rating for the company in a report on Thursday, April 9th. Piper Sandler dropped their price objective on Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating for the company in a report on Friday, February 13th. The Goldman Sachs Group dropped their price objective on Ryan Specialty from $57.00 to $49.00 and set a “buy” rating for the company in a report on Wednesday, April 8th. UBS Group dropped their price objective on Ryan Specialty from $65.00 to $59.00 and set a “buy” rating for the company in a report on Wednesday, April 8th. Finally, Royal Bank Of Canada began coverage on Ryan Specialty in a report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $47.47.

Ryan Specialty Trading Down 11.2%

NYSE:RYAN traded down $3.89 on Friday, hitting $30.89. 5,971,982 shares of the stock were exchanged, compared to its average volume of 1,920,499. The stock has a market capitalization of $8.16 billion, a price-to-earnings ratio of 73.54, a P/E/G ratio of 0.94 and a beta of 0.68. Ryan Specialty has a 52 week low of $29.91 and a 52 week high of $72.50. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. The company’s 50-day moving average price is $36.08 and its 200 day moving average price is $46.46.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The firm had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a return on equity of 41.30% and a net margin of 8.21%.The company’s quarterly revenue was up 15.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.39 EPS. On average, equities research analysts forecast that Ryan Specialty will post 2.24 earnings per share for the current year.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th will be paid a $0.13 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.7%. Ryan Specialty’s dividend payout ratio is 123.81%.

Insider Activity at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the stock in a transaction dated Monday, February 23rd. The stock was bought at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the purchase, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. The trade was a 6.33% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 52.03% of the stock is currently owned by company insiders.

Institutional Trading of Ryan Specialty

A number of institutional investors and hedge funds have recently modified their holdings of RYAN. Royal Bank of Canada increased its stake in Ryan Specialty by 10.6% during the 1st quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock worth $4,406,000 after purchasing an additional 5,739 shares in the last quarter. AQR Capital Management LLC increased its stake in Ryan Specialty by 25.1% during the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after purchasing an additional 998 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Ryan Specialty by 46.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock worth $27,787,000 after purchasing an additional 119,055 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Ryan Specialty by 11.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock worth $24,586,000 after purchasing an additional 33,667 shares in the last quarter. Finally, Creative Planning increased its stake in Ryan Specialty by 15.4% during the 2nd quarter. Creative Planning now owns 4,586 shares of the company’s stock worth $312,000 after purchasing an additional 613 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

More Ryan Specialty News

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q1 results beat expectations — EPS $0.47 vs. $0.43 est.; revenue $795.2M, +15.2% YoY and above consensus. Management reported 11.8% organic revenue growth and strong profitability metrics (ROE ~46%). This provides fundamental backing for the business after the quarter. Business Wire: Q1 Results
• Positive Sentiment: Keefe, Bruyette & Woods kept an “outperform” rating while lowering its price target to $42 (still implies sizable upside vs. current levels), offering some analyst support for the stock. Benzinga: KBW PT
• Positive Sentiment: Board announced a quarterly dividend of $0.13/share (ex-div May 12; pay May 26), an annualized yield ~1.7% — modest income support for shareholders.
• Neutral Sentiment: Earnings call transcript and additional coverage are available for detailed readouts of management commentary on growth drivers and expense trends — useful for assessing forward guidance and margin drivers. Seeking Alpha: Q1 Call Transcript
• Neutral Sentiment: Multiple outlets (Zacks, Yahoo, MSN) ran summaries noting the beat and key metrics; these amplify visibility but add little new information beyond the press release and call. Zacks: Earnings Coverage
• Negative Sentiment: Piper Sandler cut its price target from $43 to $35 and moved to “neutral” — this reduces some analyst-implied upside and likely pressured sentiment. Benzinga: Piper Sandler PT Cut
• Negative Sentiment: Wells Fargo reaffirmed an “equal weight” stance but slashed its target from $42 to $31, leaving little upside relative to the current price and adding downside risk. Benzinga: Wells Fargo PT Cut

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.